Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure
72%
Heart Failure with Preserved Ejection Fraction (HFpEF)
34%
Portugal
27%
Heart Failure Patients
23%
Chronic Heart Failure
22%
Patients with Heart Failure
18%
Acute Heart Failure
18%
Sacubitril-valsartan
15%
Quality of Life
14%
Left Ventricular Ejection Fraction
13%
Iron Deficiency
13%
Clinical Practice
13%
Worsening Heart Failure
12%
Expert Panel
12%
Preserved Ejection Fraction
12%
Heart Failure Management
11%
Heart Failure Treatment
11%
Primary Care
10%
Hospitalization
10%
Levosimendan
10%
Finerenone
10%
European Society of Cardiology
10%
Acute Decompensated Heart Failure
10%
Heart Disease Diagnosis
10%
Reduced Ejection Fraction
9%
EPICA
8%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
8%
Hyperkalemia
7%
Clinical Trials
7%
Heart Failure Hospitalization
6%
Position Paper
6%
Failure to Progress
6%
Mild Reduction
6%
Ariadne
6%
Pulmonary Embolism
6%
Hypertension
6%
Atrial Fibrillation
5%
Placebo
5%
Confidence Interval
5%
Europe
5%
Heart Failure Trials
5%
Etiology
5%
Dapagliflozin
5%
Low Risk
5%
Systolic Heart Failure
5%
Hospitalized Patients
5%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Heart Failure with Reduced Ejection Fraction
16%
Valsartan/Sacubitril
16%
Acute Heart Failure
13%
Finerenone
12%
Prevalence
10%
Diseases
10%
Clinical Trial
9%
Iron Deficiency
8%
Placebo
7%
Levosimendan
7%
Hyperkalemia
7%
Lung Embolism
6%
Systolic Heart Failure
5%
Brain Natriuretic Peptide
5%
Atrial Fibrillation
5%
Combination Therapy
5%
Angiotensin
5%
Dapagliflozin
5%
Medicine and Dentistry
Congestive Heart Failure
79%
Quality of Life
14%
Cardiology
12%
Diseases
10%
Heart Failure with Reduced Ejection Fraction
9%
Primary Health Care
9%
Acute Decompensated Heart Failure
9%
Levosimendan
9%
Ejection Fraction
8%
Iron Deficiency
8%
Prevalence
7%
Heart Left Ventricle Ejection Fraction
7%
Sacubitril
6%
Pulmonary Embolism
6%
Hyperkalemia
6%
Valsartan
5%
Brain Natriuretic Peptide
5%
Internal Medicine
5%
Clinical Trial
5%
Diuretics
5%
Echocardiography
5%